Literature DB >> 7504929

Variable expression of platelet-derived growth factor family proteins in acute lung injury.

J Walsh1, M Absher, J Kelley.   

Abstract

During acute lung injury, there is an outpouring of growth factors into the alveolar space that drive local repair and fibrosis. During the remodeling that follows the instillation of bleomycin via the trachea into the adult rat, at least two platelet-derived growth factor (PDGF)-like peptides are released sequentially into lung lining fluid. Groups of four to five animals were killed at 3, 6, 15, and 26 days after exposure to bleomycin and lungs lavaged with isotonic saline. PDGF-like peptides in epithelial lining fluid (ELF) were partially purified by cation exchange chromatography and concentrated. Isolated peptides were analyzed by immunoblotting to determine their molecular weight and immunologic identity. Western blots were probed with polyclonal antibodies to PDGF-BB and PDGF-AA. PDGF-like peptides of two distinct size classes (38-40 kD and 29 kD) were present in alveolar fluid from all rats with lung injury induced by bleomycin. No PDGF-like peptides were found in comparably prepared ELF from control animals. The 38-40 kD peptide was detected only with anti-PDGF-BB antibody; the 29 kD peptide was detected only with anti-PDGF-AA antibody. The presence of these two peptides varied independently with time after exposure to bleomycin. The 38-40 kD peptide was at peak levels at 3 to 6 days. In contrast, the 29 kD peptide was present at all times following injury but with far less variation over time. In parallel with these immunoassays for PDGF-like molecules, there was abundant growth-promoting activity for fibroblasts present in concentrated ELF during the course of injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504929     DOI: 10.1165/ajrcmb/9.6.637

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  15 in total

1.  A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.

Authors:  Koichiro Suemori; Hiroshi Fujiwara; Seiichiro Watanabe; Taichi Azuma; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2010-11-26       Impact factor: 2.490

Review 2.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

3.  Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia.

Authors:  Xuyou Zhu; Xia Fang; Wei Chen; Fei Han; Ziling Huang; Benfang Luo; Pan Gu; Long Zhang; Weizhe Qiu; Yu Zeng; Weiwei Rui; Xianghua Yi
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity.

Authors:  A E Currie; M Kelly; J R Vyas; H Pandya; D Field; S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-05       Impact factor: 5.747

6.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25

7.  Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats.

Authors:  W A Dik; R J McAnulty; M A Versnel; B A E Naber; L J I Zimmermann; G J Laurent; S E Mutsaers
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

8.  Nilotinib-induced interstitial lung disease.

Authors:  Se-Il Go; Won Sup Lee; Gyeong-Won Lee; Jung Hun Kang; Myung Hee Kang; Jeong-Hee Lee; Hoon-Gu Kim
Journal:  Int J Hematol       Date:  2013-07-23       Impact factor: 2.490

9.  Elevated platelet-derived growth factor-BB concentrations in premature neonates who develop chronic lung disease.

Authors:  Kim G Adcock; Jeremy Martin; John Loggins; Thomas E Kruger; R John Baier
Journal:  BMC Pediatr       Date:  2004-06-15       Impact factor: 2.125

Review 10.  Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis.

Authors:  Minoru Inomata; Yasuhiko Nishioka; Arata Azuma
Journal:  Core Evid       Date:  2015-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.